Phase II trial of VP16-213 in squamous cell carcinoma of the head and neck

Eur J Cancer Clin Oncol. 1987 May;23(5):577. doi: 10.1016/0277-5379(87)90323-3.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Squamous Cell / drug therapy*
  • Drug Evaluation
  • Etoposide / adverse effects
  • Etoposide / therapeutic use*
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Male
  • Middle Aged

Substances

  • Etoposide